Ticker
HBIOCompany Name
HARVARD BIOSCIENCE INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 21.33M | $ 222K | $ 0 | -1.04% |
3/31/2025 | $ 15.56M | $ 365K | $ 0 | -2.35% |
12/31/2024 | $ 28.56M | $ 380K | $ 0 | -1.33% |
9/30/2024 | $ 112.09M | $ 425K | $ 0 | -0.38% |
6/30/2024 | $ 136.07M | $ 410K | $ 0 | -0.3% |
3/31/2024 | $ 162.86M | $ 841K | $ 0 | -0.52% |
12/31/2023 | $ 195.73M | $ 930K | $ 0 | -0.48% |
9/30/2023 | $ 181.43M | $ 955K | $ 0 | -0.53% |
6/30/2023 | $ 189.11M | $ 1.02M | $ 0 | -0.54% |
3/31/2023 | $ 235.84M | $ 650K | $ 0 | -0.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for HARVARD BIOSCIENCE INC is calculated as follows: (-1 * CF - Equity [ $ 171K ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 143.04M ]
(=) Payout Yield [ -0.12% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |